These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11268434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H, Oura S, Hoffman RM, Kubota T, Furukawa T, Arimoto J, Yoshimasu T, Hirai I, Bessho T, Suzuma T, Sakurai T, Naito Y.
    Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
    [Abstract] [Full Text] [Related]

  • 3. Clinical applications of the histoculture drug response assay.
    Furukawa T, Kubota T, Hoffman RM.
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S, Udagawa Y, Kozu A, Komuro Y, Aoki D, Nozawa S, Moossa AR, Hoffman RM.
    Anticancer Res; 2000 Mar; 20(3B):2049-54. PubMed ID: 10928150
    [Abstract] [Full Text] [Related]

  • 7. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M, Iwahashi M, Nakamura M, Yamaue H.
    J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical Usefulness of the Histoculture Drug Response Assay for Breast Cancer.
    Hoffman RM, Tanino H.
    Methods Mol Biol; 2018 Sep; 1760():93-100. PubMed ID: 29572797
    [Abstract] [Full Text] [Related]

  • 10. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
    Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N.
    Cancer; 2002 Aug 15; 95(4):681-95. PubMed ID: 12209710
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y, Goto M, Hanai N, Ijichi K, Adachi M, Terada A, Hyodo I, Ogawa T, Furukawa T.
    Oral Oncol; 2007 Sep 15; 43(8):749-56. PubMed ID: 17112769
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A, Guray M, Hennessy BT, Middleton LP, Buchholz TA, Valero V, Sahin AA.
    Cancer; 2009 Apr 15; 115(8):1605-12. PubMed ID: 19197997
    [Abstract] [Full Text] [Related]

  • 13. [High clinical predictability of histoculture drug response assay (HDRA) for drug-sensitivity of cancer of the digestive organs].
    Kubota T, Furukawa T, Kitajima M.
    Gan To Kagaku Ryoho; 1993 Mar 15; 20(4):461-6. PubMed ID: 8452384
    [Abstract] [Full Text] [Related]

  • 14. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.
    Chen J, Wang L, Yao Q, Ling R, Li K, Wang H.
    Breast Cancer Res; 2004 Mar 15; 6(4):R474-7. PubMed ID: 15217515
    [Abstract] [Full Text] [Related]

  • 15. The measurement of glucose consumption in histoculture to determine effects of doxorubicin and cisplatinum on human gastric carcinoma.
    Chang SG, Chai SE, Kim ES, Yoon C, Joo HZ, Hoffman RM.
    Anticancer Res; 1993 Mar 15; 13(5A):1303-10. PubMed ID: 8239500
    [Abstract] [Full Text] [Related]

  • 16. Histoculture drug response assay, a possible examination system for predicting the antitumor effect of aromatase inhibitors in patients with breast cancer.
    Nakamura J, Imai E, Yoshihama M, Sasano H, Kubota T.
    Anticancer Res; 1998 Mar 15; 18(1A):125-8. PubMed ID: 9568066
    [Abstract] [Full Text] [Related]

  • 17. [Chemosensitivity test for 170 human breast carcinoma samples].
    He Z, Yuan J, Chen Z, Liu S, Shen Z, Fei H.
    Hunan Yi Ke Da Xue Xue Bao; 1998 Mar 15; 23(6):531-4. PubMed ID: 10806759
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity of drug resistance in human breast and ovarian cancers.
    Kern DH.
    Cancer J Sci Am; 1998 Mar 15; 4(1):41-5. PubMed ID: 9467045
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.